{"id":9834,"date":"2026-03-31T00:57:48","date_gmt":"2026-03-30T21:57:48","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=9834"},"modified":"2026-03-31T00:57:48","modified_gmt":"2026-03-30T21:57:48","slug":"ldl","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/ldl\/","title":{"rendered":"LDL <55 vs <70 mg\/dL (Ez-PAVE): Lower is Better"},"content":{"rendered":"<p><span>LDL &lt;55 vs &lt;70 mg\/dL (Ez-PAVE): Lower is Better<\/span><br \/>\n<span>\u2022 LDL &lt;55 mg\/dL \u2192 \u2193 events 33% (3 years)<\/span><br \/>\n<span>\u2022 \u2193 MI + \u2193 revascularization<\/span><\/p>\n<p><span>\u00a0More intensive LDL lowering = better outcomes<\/span><\/p>\n<p><span>Source<\/span><br \/>\n<span>\u2022 TCTMD \u2014 ACC 2026 Conference Coverage<\/span><br \/>\n<span>\u2022 NEJM (simultaneous publication)<\/span><\/p>\n<p><span>\u00a0Link (direct):<\/span><br \/>\n<a href=\"https:\/\/www.tctmd.com\/news\/very-low-ldl-levels-best-secondary-prevention-ez-pave\" target=\"_blank\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.tctmd.com\/news\/very-low-ldl-levels-best-secondary-prevention-ez-pave&amp;source=gmail&amp;ust=1774994106319000&amp;usg=AOvVaw0BYG5F3tU4G6vMl9zGX1pj\" rel=\"noopener\">https:\/\/www.tctmd.com\/news\/<wbr \/>very-low-ldl-levels-best-<wbr \/>secondary-prevention-ez-pave<\/a><\/p>\n<p><span>Practice Implication<\/span><br \/>\n<span>\u2022 Target: LDL &lt;55 mg\/dL in ASCVD<\/span><br \/>\n<span>\u2022 Strategy:<\/span><br \/>\n<span>\u2022 Statin \u2192 + Ezetimibe \u2192 \u00b1 PCSK9<\/span><br \/>\n<span>\u2022 <\/span><span>\u00a0Start early, treat aggressively<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>LDL &lt;55 vs &lt;70 mg\/dL (Ez-PAVE): Lower is Better \u2022 LDL &lt;55 mg\/dL \u2192 \u2193 events 33% (3 years) \u2022 \u2193 MI + \u2193 revascularization \u00a0More intensive LDL lowering = better outcomes Source \u2022 TCTMD \u2014 ACC 2026 Conference Coverage \u2022 NEJM (simultaneous publication) \u00a0Link (direct): https:\/\/www.tctmd.com\/news\/very-low-ldl-levels-best-secondary-prevention-ez-pave Practice Implication \u2022 Target: LDL &lt;55 mg\/dL in [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9834","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=9834"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9834\/revisions"}],"predecessor-version":[{"id":9835,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9834\/revisions\/9835"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=9834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=9834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=9834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}